Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer
- Author
- L Bosch, G Trooskens, P Snaebjornsson, J Haan, M Koopman, J Tol, T de Meyer, J Louwagie, L Dehaspe, NCT van Grieken, B Ylstra, H Verheul, M van Engeland, I Nagtegaal, JG Herman, CJA Punt, Wim Van Criekinge (UGent) , B Carvalho and GA Meijer
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-5936613
- MLA
- Bosch, L., et al. “Promoter CpG Island Hypermethylation of Decoy Receptor 1 (DCR1) Is Associated with Poor Response to Irinotecan in Metastatic Colorectal Cancer.” VIRCHOWS ARCHIV, vol. 465, no. suppl. 1, 2014, pp. S326–S326.
- APA
- Bosch, L., Trooskens, G., Snaebjornsson, P., Haan, J., Koopman, M., Tol, J., … Meijer, G. (2014). Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer. VIRCHOWS ARCHIV, 465(suppl. 1), S326–S326.
- Chicago author-date
- Bosch, L, G Trooskens, P Snaebjornsson, J Haan, M Koopman, J Tol, T de Meyer, et al. 2014. “Promoter CpG Island Hypermethylation of Decoy Receptor 1 (DCR1) Is Associated with Poor Response to Irinotecan in Metastatic Colorectal Cancer.” In VIRCHOWS ARCHIV, 465:S326–S326.
- Chicago author-date (all authors)
- Bosch, L, G Trooskens, P Snaebjornsson, J Haan, M Koopman, J Tol, T de Meyer, J Louwagie, L Dehaspe, NCT van Grieken, B Ylstra, H Verheul, M van Engeland, I Nagtegaal, JG Herman, CJA Punt, Wim Van Criekinge, B Carvalho, and GA Meijer. 2014. “Promoter CpG Island Hypermethylation of Decoy Receptor 1 (DCR1) Is Associated with Poor Response to Irinotecan in Metastatic Colorectal Cancer.” In VIRCHOWS ARCHIV, 465:S326–S326.
- Vancouver
- 1.Bosch L, Trooskens G, Snaebjornsson P, Haan J, Koopman M, Tol J, et al. Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer. In: VIRCHOWS ARCHIV. 2014. p. S326–S326.
- IEEE
- [1]L. Bosch et al., “Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer,” in VIRCHOWS ARCHIV, London, UK, 2014, vol. 465, no. suppl. 1, pp. S326–S326.
@inproceedings{5936613, articleno = {{abstract PS-20_049}}, author = {{Bosch, L and Trooskens, G and Snaebjornsson, P and Haan, J and Koopman, M and Tol, J and de Meyer, T and Louwagie, J and Dehaspe, L and van Grieken, NCT and Ylstra, B and Verheul, H and van Engeland, M and Nagtegaal, I and Herman, JG and Punt, CJA and Van Criekinge, Wim and Carvalho, B and Meijer, GA}}, booktitle = {{VIRCHOWS ARCHIV}}, issn = {{0945-6317}}, language = {{eng}}, location = {{London, UK}}, number = {{suppl. 1}}, pages = {{abstract PS-20_049:S326--abstract PS-20_049:S326}}, title = {{Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer}}, volume = {{465}}, year = {{2014}}, }